連環蛋白β1(β-catenin)單克隆抗體
Monoclonal Antibody to Beta Catenin (β-catenin)
CTNNb1; bCat; b-Cat; CTNN-B1; Catenin Beta 1; Cadherin-Associated Protein
- 編號MAB021Hu29
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來源單抗制備
- 宿主小鼠
- 效價(克隆號)C2
- Ig亞型 IgG
- 純化方式抗原特異性親和純化
- 標記物無標記物
- 免疫原 -
- 緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
- 性狀液體
- 濃度1mg/mL
- 且適物種-
- 應用WB; IHC; ICC; IP.
如果抗體需用于流式細胞術，請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 761 ¥ 1777 ¥ 2538 ¥ 6345 ¥ 25380
- 欲了解實際交易價格和更多情況，請與當地經銷商聯系!
-
產品包裝(模擬)
-
產品包裝(模擬)
-
Western Blot; Samples: Lane1: U87MG cell lysate; Lane2: SH-SY5Y cell lysate; Lane3: Porcine Cerebrum lysate; Lane4: Canine Cerebrum lysate; Lane5: Bovine Cerebrum lysate;
Primary Ab: 0.2μg/ml Mouse Anti-Human β-catenin Antibody
Second Ab: 0.2μg/ml HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19)
-
通過ISO 9001、ISO 13485質量體系認證
特異性
該抗體是針對β-catenin的小鼠單克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別β-catenin。
用法
免疫印跡：0.2-2μg/mL;1:500-5000
免疫組織化學：5-20μg/mL;1:50-200
免疫細胞化學：5-20μg/mL;1:50-200
最佳稀釋倍數最終由用戶決定。
儲存
經常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。
穩定性
熱穩定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產生。保質期內，在適當的條件下存儲，損失率低于5%。
贈品
增值服務
相關產品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應用(僅供研究使用，不用于臨床診斷！) |
| RPB021Hu01 | 連環蛋白β1(β-catenin)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB021Hu02 | 連環蛋白β1(β-catenin)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB021Hu01 | 連環蛋白β1(β-catenin)多克隆抗體 | WB; IHC; ICC; IP. |
| CAB021Hu01 | 抗連環蛋白β1(β-catenin)多克隆抗體 | Loading Control of WB. |
| MAB021Hu23 | 連環蛋白β1(β-catenin)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB021Hu24 | 連環蛋白β1(β-catenin)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB021Hu25 | 連環蛋白β1(β-catenin)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB021Hu27 | 連環蛋白β1(β-catenin)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB021Hu21 | 連環蛋白β1(β-catenin)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB021Hu22 | 連環蛋白β1(β-catenin)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB021Hu26 | 連環蛋白β1(β-catenin)單克隆抗體 | WB; IHC; ICC; IP. |
| CAB021Hu22 | 抗連環蛋白β1(β-catenin)單克隆抗體 | Loading Control of WB |
| MAB021Hu29 | 連環蛋白β1(β-catenin)單克隆抗體 | WB; IHC; ICC; IP. |
| SEB021Hu | 連環蛋白β1(β-catenin)檢測試劑盒(酶聯免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMB021Hu | 連環蛋白β1(β-catenin)等多因子檢測試劑盒(流式熒光發光法) | FLIA Kit for Antigen Detection. |
| KSB021Hu01 | 連環蛋白β1(β-catenin)檢測試劑盒DIY材料(酶聯免疫吸附試驗法) | 自己動手制作ELISA試劑盒的主要材料 |
參考文獻
| 雜志 | 參考文獻 |
| Clinica Chimica Acta | Versican and its associated molecules: Potential diagnostic markers for multiple myeloma [Pubmed:25623955] |
| Journal of Bone and Mineral Research | Adverse effects of osteocytic constitutive activation of ?-catenin on bone strength and bone growth [Pubmed:25639729] |
| Am J Transl Res | Role of SDF-1 and Wnt signaling pathway in the myocardial fibrosis of hypertensive rats [PubMed: 26396666] |
| Scientific Reports | Is there an association between enhanced choline and β-catenin pathway in breast cancer? A pilot study by MR Spectroscopy and ELISA. [pubmed:28533512] |
| Life Sciences | Hepatoprotective effect of hesperidin in hepatocellular carcinoma: Involvement of Wnt signaling pathways. [pubmed:28754618] |
| Scientific Reports | Is there an association between enhanced choline and β-catenin pathway in breast cancer? A pilot study by MR Spectroscopy and ELISA [Pubmed: 28533512] |
| The Showa University Journal of Medical Sciences | Eribulin Treatment Induces High Expression of miR-195 and Inactivates the Wnt/β-catenin Signaling Pathway in Triple-negative Breast Cancer [Doi: 10.15369/sujms.30.359] |
| Advances in?Medical?Sciences | Urinary procollagen III aminoterminal propeptide and β-catenin–New diagnostic biomarkers in solitary functioning kidney? [Pubmed: 30738287] |
| Biomed Pharmacother | Silence of FAM83H-AS1 promotes chemosensitivity of gastric cancer through Wnt/β-catenin signaling pathway [Pubmed: 32028241] |
| Journal of Cosmetic Dermatology | Novel complex of cosmetic ingredients with promising action in preventing hair loss and follicular aging through mechanism involving enrichment of WNT/signaling?… [Pubmed: 33179848] |
| Nutrients | Hydroxytyrosol as a Promising Ally in the Treatment of Fibromyalgia [Pubmed: 32784915] |
| Oncotarget | Amalgamation of PI3K and EZH2 blockade synergistically regulates invasion and angiogenesis: combination therapy for glioblastoma multiforme [33473259] |
| Cytokine | QNZ alleviated hepatocellular carcinoma by targeting inflammatory pathways in a rat model [34564023] |
留言咨詢
